Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.
Dieter is Chairman of the Board of Inspirna.
Masoud is Chief Executive Officer and co-founder of Inspirna.
Eric is the Chief Medical Officer of Hummingbird Bioscience.
Jack B. Nielsen is a Partner of Vivo Capital.
Michael is currently a research analyst at Sands Capital, a leading growth-oriented investment firm.
Antoine Papiernik is a Managing Partner at Sofinnova Partners, which he joined in 1997.
Ray is a Partner at Novo Ventures.
Peter is a Venture Partner at SR One.
Jue leads the cancer biomarker and liquid biopsy research and development at Lepu Medical.